Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment

BACKGROUND: Percutaneous coronary intervention (PCI) revolutionized treatment of coronary artery disease. Drug-eluting stents are effective and safe but their cost is high, especially for some countries. The primary objective was to evaluate the safety of methotrexate (MTX) in patients who underwent...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouveia, Viviane, Oliveira, Dinaldo C., Tenorio, Emmanuele, Brito, Norma, Sarinho, Emanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295516/
https://www.ncbi.nlm.nih.gov/pubmed/28197276
http://dx.doi.org/10.14740/cr468w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295516/
https://www.ncbi.nlm.nih.gov/pubmed/28197276
http://dx.doi.org/10.14740/cr468w

Ejemplares similares